NCT05217576View on ClinicalTrials.gov

NBM-200 Clinical Study in Blood Donation Setting

NACompletedINTERVENTIONAL

Enrollment

387

Participants

Timeline

Start Date

September 21, 2018

Primary Completion Date

November 2, 2018

Study Completion Date

November 2, 2018

Conditions

Hemoglobin H

Interventions

DEVICE

NBM-200

Finger Prick and Venipuncture

Trial Locations (3)

33624

Tampa- Dale Mabry OneBlood Donor Center, Tampa

33716

OneBlood St. Pete Main Donor Center, St. Petersburg

34684

Palm Harbor Donor Center, Palm Harbor

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

OrSense, Ltd.

INDUSTRY

lead

OneBlood, Inc.

OTHER

NCT05217576 - NBM-200 Clinical Study in Blood Donation Setting | Biotech Hunter | Biotech Hunter